Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma

Pathology - Research and Practice - Tập 211 - Trang 677-681 - 2015
Vanessa S. Machado1, Leandro Z. Crivellenti2,3, Nathieli B. Bottari4, Alexandre A. Tonin5, Luana P. Pelinson4, Sofia Borin-Crivellenti2, Aureo E. Santana2, Vanessa D. Torbitz6, Rafael N. Moresco6, Thiago Duarte7, Marta M.M.F. Duarte8, Maria Rosa C. Schetinger4, Vera M. Morsch4, Jeandre A. Jaques9, Mirela Tinucci-Costa2, Aleksandro S. Da Silva1,10
1Department of Microbiology and Parasitology, Universidade Federal de Santa Maria (UFSM), Brazil
2Department of Veterinary Clinic and Surgery, São Paulo State University (UNESP), Jaboticabal, Brazil
3Department of Veterinary Clinic and Surgery, Franca University (UNIFRAN), Franca, Brazil
4Department of Biochemistry and Molecular Biology, UFSM, Santa Maria, RS, Brazil
5Universidade do Oeste de Santa Catarina (UNOESC), Xanxerê, Brazil
6Department of Clinical and Toxicological Analysis, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil
7Department of Farmacology, UFSM, Santa Maria, RS, Brazil
8Universidade Luterana do Brasil, Santa Maria, RS, Brazil
9Laboraroty of General Biochemistry and Microorganisms, Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande, MS, Brazil
10Department of Animal Science, Universidade do Estado de Santa Catarina (UDESC), Chapecó, SC, Brazil

Tài liệu tham khảo

Henderson, 2000, Hormonal carcinogenesis, Carcinogenesis, 21, 427, 10.1093/carcin/21.3.427 Ingvarson, 2001, Breast cancer: introduction, Cancer Biol., 11, 323, 10.1006/scbi.2001.0381 Bostock, 1986, Canine and feline mammary neoplasms, Br. Vet. J., 142, 506, 10.1016/0007-1935(86)90107-7 Peleteiro, 1994, Tumores mamários na cadela e na gata, Rev. Portug. Ciênc. Vet., 89, 10 Misdorp, 2002, Tumors of the mammary gland, 575 Fonseca, 2000, Neoplasias mamárias em cadelas: influência hormonal e efeitos da ovário-histerctomia como terapia adjuvante, Cienc. Rural, 30, 731, 10.1590/S0103-84782000000400030 Zuccari, 2001, Fisiopatologia da neoplasia mamária em cadelas – revisão, Clin. Vet., 32, 50 Silva, 2004, Carcinogênese Hormonal e neoplasias hormônio-dependentes, Ciênc. Rural, 34, 625, 10.1590/S0103-84782004000200048 Nowak, 2007, Involvement of CD8+cells in protective mechanisms in canine mammary adenocarcinomas (short communication), Bull. Vet. Inst. Pul., 51, 445 Whitford, 1990, Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer, Br. J. Cancer, 62, 971, 10.1038/bjc.1990.419 Altomaa, 1992, Lymphocytes infiltrates as a prognostic variable in female breast cancer, Eur. J. Cancer, 28, 59, 10.1016/0959-8049(92)90134-N Camp, 1996, In situ cytokine production by breast cancer tumor-infiltrating lymphocytes, Ann. Surg. Oncol., 3, 176, 10.1007/BF02305798 Sica, 2008, Cancer related inflammation: the macrophage connection, Cancer Lett., 264, 204, 10.1016/j.canlet.2008.03.028 Ben-baruch, 2003, Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions, Breast Cancer Res., 31, 31 Mantovani, 2007, Inflammation and cancer: the macrophage connection, Medicina, 67, 32 Lin, 2004, Minireview role of infiltrated leucocytes in tumour growth and spread, Br. J. Cancer, 90, 2053, 10.1038/sj.bjc.6601705 Coussens, 2001, Inflammatory cells and cancer: think different!, J. Exp. Med., 193, 23, 10.1084/jem.193.6.F23 Aspord, 2007, 1037 Yoo, 2009, Cytokine expression and cancer detection, Med. Sci. Monit., 15, 49 Khanduja, 2006, Nimesulide inhibits lipopolysaccharide-induced production of superoxide anions and nitric oxide and iNOS expression in alveolar macrophages, Life Sci., 78, 1662, 10.1016/j.lfs.2005.07.033 Lima, 2001, Peroxidação lipídica: mecanismos e avaliações em amostras biológicas, Rev. Bras. Ciênc. Farmacêut., 37 Briganti, 2003, Antioxidant activity, lipid peroxidation and skin diseases, Eur. Acad. Dermatol., 17, 663, 10.1046/j.1468-3083.2003.00751.x Ralevic, 2003, Involvement of purinergic signalling in cardiovascular diseases, Drug News Perspect., 16, 40, 10.1358/dnp.2003.16.3.876886 Borovikova, 2000, Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin, Nature, 405, 458, 10.1038/35013070 Das, 2007, Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation, Med. Sci. Monit., 13, 214 Balis, 1985, Adenosine deaminase na malignant cells, Anna. N.Y. Acad. Sci., 451, 142, 10.1111/j.1749-6632.1985.tb27105.x Nieto-Cerón, 2010, Analysis of cholinesterases in human prostate and sperm implication in cancer and fertility, Chem. Biol. Interact., 187, 432, 10.1016/j.cbi.2010.03.038 Soreq, 2001, Acetylcholinesterase new roles for an old actor, Nat. Rev. Neurosci., 2, 294, 10.1038/35067589 Ruiz-Espero, 2002, Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer, Breast Cancer Res. Treat., 72, 11, 10.1023/A:1014904701723 Tatsch, 2011, A simple and inexpensive automated technique for measurement of serum nitrite/nitrate, Clin. Biochem., 44, 348, 10.1016/j.clinbiochem.2010.12.011 Hanasand, 2012, Improved detection of advanced oxidation protein products in plasma, Clin. Chim. Acta, 413, 901, 10.1016/j.cca.2012.01.038 Benzie, 1996, The ferric reducing ability of plasma (FRAP) as a measure of “Antioxidant Power”: The FRAP Assay, Anal. Biochem., 239, 70, 10.1006/abio.1996.0292 Giusti, 1974, Adenosine deaminase, 1092 Ellman, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol., 7, 88, 10.1016/0006-2952(61)90145-9 Lin, 2007, A cytokine-mediated link between innate immunity, inflammation, and cancer, J. Clin. Invest., 117, 1175, 10.1172/JCI31537 Nicolini, 2006, Cytokines in breast cancer, Cytok. Growth Fact. Rev., 17, 325, 10.1016/j.cytogfr.2006.07.002 Goldberg, 2010, Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics, Curr. Drug Targets, 11, 1133, 10.2174/138945010792006799 Kim, 2010, Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours, J. Comp. Path., 142, 177, 10.1016/j.jcpa.2009.10.023 Miles, 1994, Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue, Int. J. Cancer, 56, 777, 10.1002/ijc.2910560603 Sheen-Chen, 1997, Serum concentration of tumor necrosis factor in patients with breast cancer, Breast Cancer Res. Treat., 43, 211, 10.1023/A:1005736712307 Alshaker, 2011, IFN-γ, IL-17 and TGF-b involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors, Cancer Cell Int., 11, 33, 10.1186/1475-2867-11-33 Dunn, 2006, Interferons, immunity and cancer immunoediting, Nat. Rev. Immunol., 836, 10.1038/nri1961 Shankaran, 2001, IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122 Beatty, 2001, IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+T cells requires tumor responsiveness to IFN- γ, J. Immunol., 166, 2276, 10.4049/jimmunol.166.4.2276 Dunn, 2005, Interferon-γ and cancer immunoediting, Immunol. Res., 32, 231, 10.1385/IR:32:1-3:231 Yu, 1997, IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways, J. Leukoc. Biol., 62, 450, 10.1002/jlb.62.4.450 Kaplan, 1998, Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice, Proc. Natl. Acad. Sci. U.S.A., 95, 7556, 10.1073/pnas.95.13.7556 Piwowar, 2014, Biochemical and clinical aspects of advanced oxidation protein products in kidney diseases and metabolic disturbances, Postepy Hig. Med. Dosw, 68, 179, 10.5604/17322693.1088754 Sbarouni, 2011, Ischemia modified albumin changes: review and clinical implications, Clin. Chem. Lab. Med., 49, 177, 10.1515/CCLM.2011.037 Knowles, 1994, Nitric oxide synthases in mammals, Biochemistry, 298, 249, 10.1042/bj2980249 Ohshima, 1994, Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis, Mutation, 305, 253, 10.1016/0027-5107(94)90245-3 Lala, 1998, Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy, Cancer Metast. Rev., 17, 1, 10.1023/A:1005963400984 Tschugguel, 1999, Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade, Breast Cancer, 56, 145 Thomsen, 1994, Nitric oxide synthase activity in human gynecological cancer, Cancer Res., 54, 1352 Iwao, 2006, The structural and pharmacokinetic properties of oxidized human serum albumin and advanced oxidation protein products (AOPP), Drug Metab. Pharmacokinet., 21, 140, 10.2133/dmpk.21.140 Atabek, 2006, Protein oxidation in obesity and insulin resistance, Eur. J. Pediatr., 165, 753, 10.1007/s00431-006-0165-5 Piwowar, 2009, Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients, Br. J. Biomed. Sci., 66, 194, 10.1080/09674845.2009.11730273 Sener, 2007, Lipid peroxidation and total antioxidant status in patients with breast cancer, Cell Biochem. Funct., 25, 377, 10.1002/cbf.1308 Rao, 2007, Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease, Med. Hypoth., 69, 1272, 10.1016/j.mehy.2007.03.032 Da Silva, 2013, Relationship between butyrylcholinesterase activity and liver injury in mice acute infected with Toxoplasma gondii, Pathol. Res. Pract., 209, 95, 10.1016/j.prp.2012.10.007 Lal, 1987, Serum enzymes in head and neck cancer III, J. Laryngol. Otol., 101, 1062, 10.1017/S0022215100103226 Aghaei, 2005, Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities, Clin. Biochem., 38, 887, 10.1016/j.clinbiochem.2005.05.015